1 / 3
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
1.5 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
154.0 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 66260
- Drug name
- Levonesse, Tabletten
- Galenic form
- TAB
- ATC Code
- G03AD01
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 23/11/2016
- Authorization expiration date
- 31/12/9999
- IT Number
- 09.02.1.
- Domain
- Human medicine
Package details
- Description (FR)
- LEVONESSE cpr 1.5 mg
- Description (DE)
- LEVONESSE Tabl 1.5 mg
- Market launch
- 23/11/2016
- Narcotic (BTM)
- No